Urologist's Perspective: COVID-19 provides tough decisions—and valuable lessons
Urologists and patients show resilience, but we must be better prepared in the future, says urologist R. Jonathan Henderson, MD.
How to choose systemic therapy for metastatic RCC
Combination therapy is the first-line standard for metastatic renal cell carcinoma.
GU oncologist's perspective: pandemic poses unique challenges in vulnerable patients
Patients with cancer are particularly susceptible to negative consequences of COVID-19.
How to approach immune checkpoint inhibitor therapy in prostate cancer
Next-generation sequencing identifies subtypes that may benefit from immune checkpoint inhibitors.
How to perform office-based blue light cystoscopy
BLC with hexaminolevulinate can be an easily replicable procedure in patients with non–muscle-invasive bladder cancer.
